• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXHS2000038 奥瑞巴替尼片 Olverembatinib Tablet Chemical Drugs(1) New Drug Application 2020-10-10 广州顺健生物医药科技有限公司 Guangzhou Shunjian Biomedical Technology Co Ltd;Haimen PHARMA INC In Review 2022-01-19 view